Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12618000885291Phase 4Recruiting
Phase 4, randomised trial of citalopram (2 arms), sponsored by Monash University. Primary endpoint: Change in suprachiasmatic area activation to light. Started Jun 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12618000885291.